nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multilevel analysis on the determinants of regional health care expenditure: a note
|
López-Casasnovas, Guillem |
|
2006 |
8 |
1 |
p. 59-65 |
artikel |
2 |
A public–private analysis of the new Dutch health insurance system
|
Maarse, Hans |
|
2006 |
8 |
1 |
p. 77-82 |
artikel |
3 |
Better primary physician services lead to fewer hospital admissions
|
Carlsen, Fredrik |
|
2006 |
8 |
1 |
p. 17-24 |
artikel |
4 |
Cost of breast cancer in Sweden in 2002
|
Lidgren, Mathias |
|
2006 |
8 |
1 |
p. 5-15 |
artikel |
5 |
Economic evaluation for pharmaceuticals in Germany
|
Jönsson, Bengt |
|
2007 |
8 |
1 |
p. 1-2 |
artikel |
6 |
Long-term absenteeism due to sickness in Sweden. How long does it take and what happens after?
|
Andrén, Daniela |
|
2007 |
8 |
1 |
p. 41-50 |
artikel |
7 |
Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
|
Brüggenjürgen, B. |
|
2006 |
8 |
1 |
p. 51-57 |
artikel |
8 |
Methods for determining cost-benefit ratios for pharmaceuticals in Germany
|
Graf v. d. Schulenburg, J.- Matthias |
|
2007 |
8 |
1 |
p. 5-31 |
artikel |
9 |
Resource use and costs associated with patients treated for depression in primary care
|
Sobocki, P. |
|
2006 |
8 |
1 |
p. 67-76 |
artikel |
10 |
Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set
|
Behrend, Corinne |
|
2007 |
8 |
1 |
p. 31-39 |
artikel |
11 |
Should we really worry about “launch delays” of new drugs in OECD countries?
|
Garattini, Livio |
|
2006 |
8 |
1 |
p. 1-3 |
artikel |
12 |
Technology assessment in the German context
|
Drummond, Michael |
|
2007 |
8 |
1 |
p. 3 |
artikel |
13 |
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy
|
Lindgren, Peter |
|
2006 |
8 |
1 |
p. 25-30 |
artikel |